Jasper Therapeutics, Inc. · NASDAQ:JSPR

Anders Hove reported a 5.30% stake in Jasper Therapeutics, Inc. (Schedule 13G/A)

Event Jan 23, 2026 · Filed Jan 26, 2026

Anders Hove reported a 5.30% stake in Jasper Therapeutics, Inc., 1,486,492 shares, as a passive investor on Jan 23, 2026. Filed Jan 26, 2026 (Schedule 13G/A).

Stake
5.30%
Shares
1,486,492
Intent
Passive
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
ACORN BIOVENTURES, L.P.2.20%624,326
ACORN CAPITAL ADVISORS GP, LLC2.20%624,326
ACORN BIOVENTURES 2, L.P.3.10%862,166
Acorn Capital Advisors GP 2, LLC3.10%862,166
Anders Hove5.30%1,486,492

Source

View original at SEC

Related